Synopsis: Hyderabad’s CCMB scientists have identified two genes, NR2F1 and NR2F6, that helped damaged spinal cord nerves regenerate and improved movement in mice. Published in The EMBO Journal, the findings reveal potential pathways for nerve repair, but further research is needed before these discoveries can translate into treatments for human spinal cord injuries.
A spinal cord injury can change a person’s life in an instant. When the injury damages the nerve fibres carrying movement signals between the brain and the body, it can result in paralysis. Unlike nerves in the arms and legs, which retain some ability to regenerate, damaged nerve fibres in the adult brain and spinal cord rarely grow back.
Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, have now identified two genes that could help overcome this limitation. In experiments involving mice, activating the genes NR2F1 and NR2F6 encouraged damaged nerve fibres to grow across injured regions of the spinal cord. It led to measurable improvements in movement and grip strength.
The findings, published in The EMBO Journal in a study titled Nuclear Receptor Transcription Factors Promote Axon Regeneration in the Adult Corticospinal Tract, suggest that adult neurons may retain the genetic instructions needed for regeneration, but lose access to them as they mature.
Dr Ishwariya Venkatesh led the research, with Yogesh Sahu as the first author.
Regeneration is not absent in nature. Zebrafish, for instance, can regrow nerve fibres in their brain and spinal cord after an injury. Even in humans, nerves in the arms and legs retain some capacity to regenerate. During embryonic development, neurons also readily extend long fibres to establish connections.
But this ability declines as mammalian neurons mature. The researchers found that genes associated with nerve growth remain present in adult neurons, but their activity decreases as the brain develops.
To understand what switches off this regenerative ability, the team examined developing mouse brains and studied the proteins that bind to genes involved in nerve growth. They identified two transcription factors, NR2F1 and NR2F6, which had not previously been linked to nerve regeneration in the brain or spinal cord.
The activity of both proteins declined substantially as the brain matured. NR2F1 fell by approximately 69% from its developmental peak, while NR2F6 declined by around 78%.
The researchers then investigated whether restoring their activity could reactivate the growth mechanisms in adult neurons.
“Adult neurons have not lost the programme for regrowth; it has been silenced as the brain matures,” said Dr Venkatesh. “What this work shows is that two different molecular routes can bring that programme back, and both lead to recovery.”
The researchers first introduced NR2F1 and NR2F6 into neuronal cells using adeno-associated virus vectors. Both proteins increased the growth of nerve-cell projections, known as neurites, compared with untreated cells.
They then tested the approach in adult mice using two models of spinal cord injury. In one experiment, they interrupted one side of the corticospinal tract, a major nerve pathway through which the brain controls voluntary movement. Activating either protein encouraged nerve fibres from the uninjured side to grow across the spinal cord’s midline and into the damaged region.
In another experiment, the researchers caused a severe crush injury at the T8 level of the spinal cord. They found that nerve fibres in mice treated with NR2F1 or NR2F6 grew across the injured region and extended beyond it. In untreated animals, the fibres remained stunted and stopped near the injury site.
NR2F1 produced nerve growth extending up to 1,500 micrometres beyond the injury, while NR2F6 also promoted regeneration, with statistically significant effects detected up to 1,000 micrometres.
The researchers also examined whether the regrowth translated into improvements in movement. Mice receiving NR2F1 began showing improvements in hindlimb movement from the fifth week after injury, while those receiving NR2F6 showed improvements from the seventh week.
Both groups demonstrated better grip strength than untreated animals. The treated mice could lift their hindlimbs and move their toes backwards during the stepping cycle, indicating partial recovery of movement.
However, the recovery was not complete. The mice did not fully regain the forward swinging movement required for a normal walking stride.
The researchers also investigated how the two proteins stimulated regeneration. They found that NR2F1 and NR2F6 worked through different molecular mechanisms, even though both improved nerve growth and movement.
NR2F1 activated pathways involved in reorganising chromatin, the structure that packages DNA inside cells, and rebuilding the cell’s internal scaffolding. These changes helped recreate conditions associated with the growth-capable state of developing neurons.
NR2F6 followed a different route. It reduced the activity of many genes, including those involved in routine protein production, while selectively preserving growth-related programmes needed for nerve repair. The researchers found that more than 4,000 genes were affected by NR2F6, with approximately 93% showing reduced expression.
The team also observed that NR2F6 reorganised the three-dimensional structure of DNA inside injured neurons, creating new folded domains that brought growth-related genes closer to their regulatory switches.
This finding challenges the conventional understanding that nerve regeneration necessarily requires an increase in protein production. In this experiment, reducing the activity of several genes while preserving specific growth programmes helped neurons redirect resources towards rebuilding damaged nerve fibres.
The findings offer a potential direction for developing treatments that target the regenerative ability of nerve cells rather than only managing the consequences of spinal cord injuries.
However, the research remains preclinical. The experiments were conducted in mice, and the recovery observed was partial, not a complete restoration of movement.